Autolus Therapeutics Ltd (AUTL) — Cash Flow-to-Debt Ratio
Autolus Therapeutics Ltd (AUTL) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of $-65.32 Million could theoretically repay 0% of its total liabilities ($418.24 Million) in one year. Explore how efficiently does Autolus Therapeutics Ltd generate cash to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Autolus Therapeutics Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Autolus Therapeutics Ltd across 12 annual periods. Also explore Autolus Therapeutics Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Autolus Therapeutics Ltd (2015–2025)
Year-by-year debt coverage analysis for Autolus Therapeutics Ltd. For market capitalisation and broader financial context, see AUTL market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.69x | $-283.57 Million | $410.94 Million | ▼ -18.9% |
| 2024 | -0.58x | $-206.27 Million | $355.40 Million | ▼ -5.2% |
| 2023 | -0.55x | $-145.59 Million | $263.91 Million | ▲ +5.9% |
| 2022 | -0.59x | $-112.31 Million | $191.60 Million | ▲ +54.1% |
| 2021 | -1.28x | $-117.86 Million | $92.24 Million | ▲ +8.6% |
| 2020 | -1.40x | $-117.76 Million | $84.20 Million | ▲ +32.9% |
| 2019 | -2.08x | $-101.48 Million | $48.69 Million | ▼ -0.9% |
| 2018 | -2.06x | $-25.85 Million | $12.52 Million | ▲ +0.0% |
| 2018 | -2.06x | $-25.85 Million | $12.52 Million | ▲ +23.5% |
| 2017 | -2.70x | $-16.36 Million | $6.06 Million | ▲ +4.3% |
| 2016 | -2.82x | $-9.85 Million | $3.49 Million | ▼ -65.2% |
| 2015 | -1.71x | $-3.33 Million | $1.95 Million | — |